ABSTRACT
Objective: to observe the effect of abdominal obesity on fasting blood glucose levels in T2DM patients who are on treatment with oral hypoglycemic agents
Material and Methods: the study included 55 T2DM patients, who were taking oral hypoglycemic drugs for the last 3 to 5 years. Abdominal obesity was assessed by measuring waist circumference. Fasting blood glucose levels were measured in all patients
ResuIts: according to our observation there were 41.81% non-obese, 23.63% overweight and 34.54% obese T2DM patients. The obese T2DM patients had significantly higher mean fasting blood glucose level as compared to nun-obese and overweight T2DM patients [p<0.001]. Overweight T2DM patients though had higher mean fasting plasma glucose levels as compared to non-obese T2DM patients but it was not significant
Conclusion: Abdominal obesity is associated with significantly higher fasting blood glucose levels in T2DM patients who are on treatment with oral hypoglycemic agents